Skip to main content
Top

Cancer Causes & Control

Issue 2/2002

Content (11 Articles)

Projecting SEER cancer survival rates to the US: an ecological regression approach

Angela Mariotto, Riccardo Capocaccia, Arduino Verdecchia, Andrea Micheli, Eric J. Feuer, Linda Pickle, Limin X. Clegg

Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa Women's Health Study (United States)

James R. Cerhan, Thomas M. Habermann, Celine M. Vachon, Shannon D. Putnam, Wei Zheng, John D. Potter, Aaron R. Folsom

Sinonasal cancer and occupational exposures: a pooled analysis of 12 case–control studies

Danièle Luce, Annette Leclerc, Denis Bégin, Paul A. Demers, Michel Gérin, Ewa Orlowski, Manolis Kogevinas, Stefano Belli, Isabelle Bugel, Ulrich Bolm-Audorff, Louise A. Brinton, Pietro Comba, Lennart Hardell, Richard B. Hayes, Corrado Magnani, Enzo Merler, Susan Preston-Martin, Thomas L. Vaughan, Wei Zheng, Paolo Boffetta

A case–control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States)

J.C. Schroeder, A.F. Olshan, R. Baric, G.A. Dent, C.R. Weinberg, B. Yount, J.R. Cerhan, C.F. Lynch, L.M. Schuman, P.E. Tolbert, N. Rothman, K.P. Cantor, A. Blair

Practical implications of imposing a new world standard population

Freddie Bray, Agathe Guilloux, Risto Sankila, Donald M. Parkin

A prospective study of life satisfaction, neuroticism and breast cancer risk (Finland)

Kirsi Lillberg, Pia K. Verkasalo, Jaakko Kaprio, Lyly Teppo, Hans Helenius, Markku Koskenvuo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine